Tag Archives: ticagrelor
Higher ticagrelor mortality in the FDA adverse event repository: time to stop TV ads?
Despite broad utilization of oral P2Y12 platelet inhibitors such as clopidogrel, prasugrel, and ticagrelor, the comparative mortality risks of each agent are unknown. Moreover, few available randomized data are challenged with restricted populations, double – digit drug
